Resources

Selected
  • COVID-19
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)

1599 results found

2024 ∙ Mostafavi, F. Bahardoust, M. Sera, F. Amirabadizadeh, A. Allahyari, S. Ssentongod, P. Karami, M. Hashemi Nazari, S. S.

COVID-19 Vaccine Effectiveness of Booster Doses Against Delta and Omicron Variants Over Follow-up Times Using Longitudinal Meta-analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Sangeetha, M. D. Menon, P. K. S. Kharmawphlang, B. K. Shivashankarappa, D. H. Nagaraja, S. B.

COVID-19 Vaccine Hesitancy among Adults in India: A Systematic Review and Meta-analysis

  • South-East Asia
  • India
  • Adults
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Alalawi, M. Alsalloum, M. A. Garwan, Y. M. Abuzeid, M. Alalawi, H. Eljaaly, K. Thabit, A. K. Jose, J.

COVID-19 vaccine hesitancy among healthcare workers in Arab Countries: A systematic review and meta-analysis

  • Eastern Mediterranean
  • Healthcare workers
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Iqbal, S. Qudah, T. Ali, I. Abid, J. Ahmad, A. M. R.

COVID-19 vaccine hesitancy among medical students, health professionals, and health care workers: an umbrella review

  • All age groups
  • Healthcare workers
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Liu, X. Wu, Y. Huo, Z. Zhang, L. Jing, S. Dai, Z. Huang, Y. Si, M. Xin, Y. Qu, Y. Tang, S. Su, X.

Covid-19 vaccine hesitancy among people living with hiv: A systematic review and meta-analysis

  • All age groups
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Ramonfaur, D. Limaye, R. J. Hinojosa-Gonzalez, D. E. Barrera, F. J. Rodriguez-Gomez, G. P. Castillo-Salgado, C.

COVID-19 vaccine hesitancy prevalence in Mexico: A systematic review and metanalysis

  • Americas
  • Mexico
  • All age groups
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Rahbeni, T. A. Satapathy, P. Itumalla, R. Marzo, R. R. Mugheed, K. A. L. Khatib, M. N. Gaidhane, S. Zahiruddin, Q. S. Rabaan, A. A. Alrasheed, H. A. Al-Subaie, M. F. Al Kaabil, N. A. Alissa, M. Ibrahim, Aaal Alsaif, H. A. Naser, I. H. Rustagi, S. Kukreti, N. Dziedzic, A.

COVID-19 Vaccine Hesitancy: Umbrella Review of Systematic Reviews and Meta-Analysis

  • All age groups
  • Healthcare workers
  • Pregnant women
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Angeles, G. E. D. Dichoso, L. P. C. Jamora, R. D. G.

COVID-19 vaccine related movement disorders: a systematic review

  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Abuhammad, A. Albandak, M. Ayyad, M. Refayeh, E. Qawasma, B. Hour, S. Abu Thraiee, Y. Sowaity, Z. A. Dukmak, O. Jobran, A. W. M. Alamleh, L.

COVID-19 vaccine-associated vasculitis: A systematic review

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Grace-Elysse, D. Angeles Lowrence-Precious, C. Dichoso Roland-Dominic, G. Jamora

COVID-19 Vaccine-Related Movement Disorders: A Systematic Review

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
Loading...